Zelda Therapeutics Partners With US Children’s Hospital For Autism Study

Australia’s Zelda Therapeutics Ltd (ASX: ZLD) has teamed up with Children’s Hospital of Philadelphia (CHOP) to study the pharmacology of cannabinoids , with a focus on the potential for treating autism. As we mentioned on Monday, Zelda stock went into a trading halting pending the announcement of a … Read More

The post Zelda Therapeutics Partners With US Children’s Hospital For Autism Study appeared first on Dagga Magazine.

…read more

Leave a Reply

Your email address will not be published. Required fields are marked *